Moreover, immunohistochemical analysis of matched patient‐derived primary breast tumors and lung metastases revealed heterogeneous JNK signaling within both primary tumors and metastases, based on activated c‐Jun (Fig 1B). The gene discussed is MAPK8; the disease is breast neoplasm.